Stress-induced mitochondrial depolarization and oxidative damage in PSP cybrids

Brain Research

Volumn 951, Issue 1, 2002, Pages 31-35

  Chirichigno, Jason W ^a   Manfredi, Giovanni ^a   Beal, M Flint ^a   Albers, David S ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Energy metabolism; Free radical; Mitochondria; Mitochondrial DNA; PSP

Indexed keywords

MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE;

ARTICLE; CELL LINE; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; CYBRID; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPID OXIDATION; LIPID PEROXIDATION; MEMBRANE POTENTIAL; MITOCHONDRIAL GENETICS; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RESPIRATORY CHAIN;

BRAIN; DNA, MITOCHONDRIAL; ENERGY METABOLISM; HUMANS; HYBRID CELLS; INTRACELLULAR MEMBRANES; LIPID PEROXIDATION; MITOCHONDRIA; MITOCHONDRIAL DISEASES; OXIDATIVE STRESS; SUPRANUCLEAR PALSY, PROGRESSIVE; TOXINS, BIOLOGICAL;

EID: 0037183712     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03101-3     Document Type: Article

References (17)

1. Steele J., Richardson J., Olszewski J. Progressive supranuclear palsy. A heterogeneous degeneration involving the brainstem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch. Neurol. 10:1964;333-359.
2. Albers D.S., Augood S.J. New insights into progressive supranuclear palsy. Trends Neurosci. 24:(6):2001;347-353.
3. Albers D.S., Augood S.J., Park L.C.H., Browne S.E., Martin D.M., Adamson J., Hutton M., Standaert D.G., Vonsattel J.P.G., Gibson G.E., Beal M.F. Frontal lobe dysfunction in PSP: evidence for oxidative stress and mitochondrial impairment. J. Neurochem. 74:2000;878-881.
4. DiMonte D., Harati Y., Jankovic J., Sandy M., Jewell S., Langston J. Muscle mitochondrial ATP production in progressive supranuclear palsy. J. Neurochem. 62:1994;1631-1634.
5. Martinelli P., Scaglione C., Lodi R., Iotti S., Barbiroli B. Deficit of brain and skeletal muscle bioenergetics in progressive supranuclear palsy shown in vivo by phosphorus magnetic resonance spectroscopy. Mov. Disord. 15:2000;889-893.
6. Swerdlow R.H., Parks J.K., Cassarino D.S., Maguire D.J., Maguire R.S., Bennett J.P. Jr., Davis R.E., Parker W.D. Jr. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 40:1996;663-671.
7. Swerdlow R.H., Park J.K., Cassarino D.S., Maguire D.J., Maguire R.S., Bennett J.P., Parker W.D. Jr. Cybrids in Alzheimer's disease: a cellular model of disease? Neurology. 49:1997;918-925.
8. Swerdlow R.H., Parks J.K., Cassarino D.S., Trimmer P.A., Miller S.W., Maguire D.J., Sheehan J.P., Maguire R.S., Pattee G., Juel V.C., Phillips L.H., Tuttle J.B., Bennett J.P. Jr., Davis R.E., Parker W.D. Jr. Mitochondria in sporadic amyotrophic lateral sclerosis. Exp. Neurol. 153:1998;135-142.
9. Swerdlow R.H., Golbe L.I., Parks J.K., Cassarino D.S., Binder D.R., Grawey A.E., Litvan I., Bennett J.P. Jr., Wooten G.F., Parker W.D. Jr. Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with PSP. J. Neurochem. 75:2000;1681-1684.
10. Albers D.S., Swerdlow R.H., Manfredi G., Gajewski C., Yang L., Parker W.D. Jr., Beal M.F. Further evidence for mitochondrial dysfunction in progressive supranuclear palsy. Exp. Neurol. 168:2001;196-198.
11. Trounce I.A., Kim Y.L., Jun A.S., Wallace D.C. Assessment of mitochondrial oxidative phosphorylation in muscle biopsies, lymphoblasts and transmitochondrial cell lines. Methods Enzymol. 264:1996;484-509.
12. Scanlon J.M., Reynold I.J. Effects of oxidants and glutamate receptor activation on mitochondrial membrane potential in rat forebrain neurons. J. Neurochem. 71:1998;2392-2400.
13. Sawa A., Wiegand G.W., Cooper J., Margolis R.L., Sharp A.H., Lawler J.F., Greenamyre J.T., Snyder S.H., Ross C.A. Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat. Med. 5:1999;1194-1198.
14. Albers D.S., Beal M.F. Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease. J. Neural Transm. Suppl. 59:2000;133-154.
15. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 82:2002;47-95.
16. Beal M.F. Energetics in the pathogenesis of neurodegenerative diseases. Trends Neurosci. 23:2000;298-304.
17. Fosslein E. Mitochondrial medicine: molecular pathology of defective oxidative phosphorylation. Ann. Clin. Lab. Sci. 31:2001;25-67.